Insights

Expansion & capacity SCHOTT Pharma is actively expanding manufacturing capacity, notably investing over €100m in its Hungary site to add sterile ready-to-use cartridge production. This signals growing demand in sterile containment solutions and opportunities to cross-sell RTU cartridge systems and related safety/packaging innovations.

Strategic collaborations Recent partnerships with Nemera for compatible large-volume passive safety systems and with Ypsomed to simplify home self-administration indicate a push toward integrated delivery solutions and patient-centric devices, creating openings to offer end-to-end containment, syringes, safety systems, and related services.

Sustainability push Introduced closed-loop recycling for vial trays and recycled-material packaging coordinates with regulatory and sustainability trends, suggesting opportunities to position eco-friendly packaging, material substitution, and waste-reduction consulting to pharma clients aiming to improve ESG profiles.

Global footprint Sixteen manufacturing sites across Europe, the Americas, and Asia combined with a wide customer base including top 30 pharma manufacturers presents cross-regional sales opportunities for standardized containment and delivery platforms, as well as scalable support and regulatory expertise.

Innovation engine A robust in-house IP portfolio and a state-of-the-art R&D center enable co-development opportunities for new syringe, cartridge, and vial technologies, making SCHOTT Pharma a strong partner for early-stage programs, retrofit projects, and alliances around next-generation delivery systems.

Similar companies to SCHOTT Pharma

SCHOTT Pharma Tech Stack

SCHOTT Pharma uses 8 technology products and services including Microsoft Advertising, Linkedin Insight Tag, SAP SuccessFactors, and more. Explore SCHOTT Pharma's tech stack below.

Media & News

SCHOTT Pharma's Email Address Formats

SCHOTT Pharma uses at least 3 email formats:
SCHOTT Pharma Email FormatsExamplePercentage
First.Last@schott.comJohn.Doe@schott.com
98%
Last.First@schott.comDoe.John@schott.com
1%
First.Middle@schott.comJohn.Michael@schott.com
1%

Frequently Asked Questions

What is SCHOTT Pharma's official website and social media links?

Minus sign iconPlus sign icon
SCHOTT Pharma's official website is schott-pharma.com and has social profiles on LinkedIn.

How much revenue does SCHOTT Pharma generate?

Minus sign iconPlus sign icon
As of October 2026, SCHOTT Pharma's annual revenue is estimated to be $1B - $10B.

What is SCHOTT Pharma's NAICS code?

Minus sign iconPlus sign icon
SCHOTT Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SCHOTT Pharma have currently?

Minus sign iconPlus sign icon
As of October 2026, SCHOTT Pharma has approximately 1.3K employees across 4 continents, including Europe, South America and North America. Key team members include Cio: C. B., Vice President Global Sales & Marketing: C. P. and Vice President & Head Of Glass Syringes: C. H. Explore SCHOTT Pharma's employee directory with LeadIQ.

What industry does SCHOTT Pharma belong to?

Minus sign iconPlus sign icon
SCHOTT Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does SCHOTT Pharma use?

Minus sign iconPlus sign icon
SCHOTT Pharma's tech stack includes Microsoft Advertising, Linkedin Insight Tag, SAP SuccessFactors, Power BI, Microsoft SharePoint, OpenAI, Kronos and MouseFlow.

What is SCHOTT Pharma's email format?

Minus sign iconPlus sign icon
SCHOTT Pharma's email format typically follows the pattern of First.Last@schott.com. Find more SCHOTT Pharma email formats with LeadIQ.

When was SCHOTT Pharma founded?

Minus sign iconPlus sign icon
SCHOTT Pharma was founded in 1884.
SCHOTT Pharma logo

SCHOTT Pharma

Pharmaceutical ManufacturingRhineland-palatinate, Germany1001-5000 Employees

SCHOTT Pharma, based in Mainz, Germany, designs and manufactures drug containment and delivery systems for injectable medicines. Its portfolio includes prefillable glass and polymer syringes, cartridges, vials, and ampoules intended to enhance safety and usability. The company serves a global customer base that includes many of the top manufacturers of injectable drugs and operates across 16 sites worldwide, with an R&D center in Switzerland. A multinational workforce from more than 60 nations supports its operations, and the firm is part of SCHOTT AG, owned by the Carl Zeiss Foundation. In 2026, it announced expansion of its Lebanon, Pennsylvania facility to increase capacity for core and specialty vials, reflecting ongoing growth.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1884
Employees
1001-5000

Section iconFunding & Financials

  • $1B - $10B

    SCHOTT Pharma's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.